US Patent Issued to Dana-Farber Cancer Institute on Jan. 13 for "Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereof" (Massachusetts, Illinois Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,583, issued on Jan. 13, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereof" was invented by Nathanael S. Gray (Boston), Tinghu Zhang (Brookline, Mass.), Yao Liu (Brookline, Mass.), David Weinstock (Jamaica Plain, Mass.) and Loretta Sze-Mun Li (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof. The provided compo...